United European Gastroenterology Journal

Article	Citations
	195
Table of Contents	173
UEG Week 2023 Oral Presentations	123
Medical guidelines must not be influenced by commercial interests	112
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response	99
UEG's prospects for the future	94
Stunned by a stone—A curious case of belly trouble	73
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study	73
Shedding a new light on gastric cancer screening	68
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?	65
Letter of Thanks for UEG Week 2022 Reviewers	63
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps	52
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018	48
Upcoming Treatments in Celiac Disease: From Luminal Enzymes to Oral Immune Tolerance	46
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ	46
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature	46
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta‐Analysis	45
From Postoperative Prognosis to Preoperative Decision‐Making in IPMN	45
Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study	42
Corticosteroid Use in Childhood‐Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006–2022)	42
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers	40
Recent developments in the management of ascites in cirrhosis	39
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study	39
Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era	39
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study	37

Correction to “Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility”	37
Dermatitis Herpetiformis in Celiac Disease: A Systematic Review and Meta‐Analysis	36
Giant Meckel's Diverticulum Mimicking Crohn's Disease: Double‐Stricture Deception	36
	35
Issue Information	35
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management	35
Primary malignant melanoma of the oesophagus	34
	34
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”	34
Association of circulating Z‐polymer with adverse clinical outcomes and liver fibrosis in adults with alpha‐1 antitrypsin deficiency	32
The assessment and management of cirrhotic patients with encephalopathy	31
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases?	31
Transcutaneous Auricular Vagal Nerve Stimulation to Treat Chronic Constipation: Another Therapeutic Failure?	29
Issue Information	29
Oral Microcapsule Chromocolonoscopy With Patent Blue V Improves Adenoma Detection Safely and Effectively	29
Issue Information	28
The Pivotal ‘P’s of inflammatory bowel disease: Prediction and Prevention	28
Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle	28
From Guideline to Clinical Practice: Towards an Era Without Surgical Site Infections	28
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study	27
Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study	27
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?	27
Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial	27
What the European Reference Network Registry for Rare Liver Diseases Tells Us About Primary Biliary Cholangitis in European Practice	26
T1 colorectal cancer patients' perspective on information provision and therapeutic decision‐making after local resection	26
Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications	26
Inaccuracy and Bias in Endoscopic Size Estimation of Large Colorectal Polyps; Insights From a Prospective Cohort of 1828 En‐Bloc Resections	26
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma	26
Issue Information	25
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives	25
Dedicated Endoscopy for Barrett's Oesophagus With Higher Dysplasia Yield May Reduce Seattle Protocol Biopsies: Results From UK Multicentre Study	25
Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease	24
Issue Information	24
Secondary Prophylaxis of Cirrhotic Gastric Variceal Bleeding: Addition of Non‐Selective Beta‐Blockers to Endoscopic Combined Treatment	24
Issue Information	24
Gutflix ‘How to Develop Guidelines’ Series	24
Diagnostic value of radiological staging and surveillance for T1 colorectal carcinomas: A multicenter cohort study	23
UEG journal's editorial team	23
Psychological Factors Predict Response to a Low Fermentable Oligo‐, di‐, Monosaccharide and Polyol Dietary Intervention in Irritable Bowel Syndrome: A Prospective Cohort Study	22
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis	22
Faecal incontinence with concurrent disorders of gut‐brain interaction: A worse outcome	22
Editorial: Reducing Post‐Endoscopy Upper Gastrointestinal Cancer—Less Is More?	22
Homologous Repair‐Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy	21
Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial	21
Variation in the detection of lymphovascular invasion in T1 colorectal cancer and its impact on treatment: A nationwide Dutch study	21
Sphingosine‐1‐Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety	21
Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement	21
Fatty Pancreas and Risk of Type 2 Diabetes, Chronic Kidney Disease and Cardiovascular Events: Evidence From a Population‐Based Cohort	20
Environmental risk factors for inflammatory bowel disease	20
Pancreatic “supercyst”	20

Issue Information	20
Response to “Reflections on the Study of Physiological Determinants in Cirrhosis With Ascites”	20
	20
Clinical, Dietary, Lifestyle and Genetic Factors Associated With Age at Onset of Esophageal Adenocarcinoma	20
	20
Hepatic Artery Aneurysm Rupture After Double‐Balloon Endoscopy in Biliary Atresia	20
A Roadmap for Advancing Women's Health in Disorders of the Gut‐Brain Interaction	19
	19
Splenic artery embolisation for splenic injury during colonoscopy: A systematic review	19
Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort	18
Recent advances in the treatment of refractory gastrointestinal angiodysplasia	18
Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities	18
Incidence, characteristics, and predictive factors of post‐colonoscopy colorectal cancer	18
The Pitfalls of Measuring Burnout Prevalence: μετά the Meta‐Analysis, What Then?	18
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters?	18
Chronic and Idiopathic Pancreatitis—A Personalized Treatment Approach	17
European Guideline on Pre‐Operative Prevention of Surgical Site Infections Following Digestive Surgery: A Joint Update of the WHO SSI Guideline for Gastrointestinal Surgery by UEG, ESCP, EAES, and SIS	17
Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study	17
Long‐term outcomes of endoscopic ultrasound‐guided hepaticogastrostomy in patients with malignant biliary obstruction	17
An education‐based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study)	17
Sex‐related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registry	17
A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey	17
Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Novel Mechanisms and Prevention by Drugs	17
Increased risk of obstructive lung disease in inflammatory bowel disease: A population‐based cohort study	16
The Clinical Reality of Endoscopic Sedation: Balancing Pharmacokinetic Efficiency With Diagnostic Excellence	16
	16
	16
Intrahepatic splenosis mimicking hepatocellular carcinoma	16
Artificial Intelligence in FIT‐Positive Colonoscopy: Balancing Detection Metrics and Clinical Impact	16
AEG‐AESPANC‐OPGE‐SIED‐SPG Ibero‐Latin American Guidelines on Acute Pancreatitis (iLATAM‐AP)	16
	16
Are Education, Socioeconomic Status, and Household Size Dependent Variables Influencing the Developmental Origins of Inflammatory Bowel Disease?	15
Microlithiasis‐Induced Acute Papillitis Triggers Acute Pancreatitis: Where Do We Go From Here?	15
Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort	15
UEG Week 2025 Nurse Programme Presentations	15
Multi‐Omics Analysis of Ileal Mucosa and Mesentery Before and After Ileocecal Resection in Crohn's Disease	15
Longitudinal Surveillance of Gastric Polyposis in Familial Adenomatous Polyposis: Incidence, Progression, and Endoscopic Outcomes	15
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?	15
Letter of Thanks for UEG Week 2025 Reviewers	15
Issue Information	15
Challenges with neuropsychiatric Wilson's disease	15
Gastroenterology Training and Career in Women: Challenges and Opportunities	14
Issue Information	14
Real‐World Molecular Testing in European Early‐Onset Colorectal Cancer	14
Global trends in opioid use for pain management in acute pancreatitis: A multicentre prospective observational study	14
UEG week and UEG journal: A strong scientific liaison	14
Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to Ustekinumab	14
Beyond the numbers: United European Gastroenterology journal's mission to build a community and connect	14
Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study	14
Correction to European Consensus on Functional Bloating and Abdominal Distension—ESNM/UEG Recommendations for Clinical Management	13
Gut Microbial Signatures Associated With Clinical Remission in Inflammatory Bowel Disease Treated With Biologics: A Comprehensive Multi‐Cohort Analysis	13
New endoscopic tools in inflammatory bowel disease	13
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis	13
Clinical relevance of calprotectin in patients with perianal fistulas in Crohn's disease and cryptoglandular fistulas	13
Issue Information	13
Effective Colorectal Cancer Screening—Adherence is Key	13
Effectiveness of Gastric Cancer Endoscopic Screening in Intermediate‐Risk Countries—A Systematic Review and Meta‐Analysis	13
ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta‐analysis on inflammatory bowel disease risk and clinical outcomes	13
Wilson's disease—An early diagnosis to improve outcomes	13
Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort	13
Endoscopic management of duodenal perforation caused by foreign bodies in adults: A retrospective study	13
Peroral endoscopic myotomy for hypercontractile (Jackhammer) esophagus: A retrospective multicenter series with long‐term follow‐up	13
Efficacy of different bowel preparation regimen volumes for colorectal cancer screening and compliance with European Society of Gastrointestinal Endoscopy performance measures	12
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort	12
No evidence of association between inherited thrombophilia and increased risk of liver fibrosis	12
Diagnosing Disorders of the Gut‐Brain Interaction: When to Sound the Alarm?	12
European Consensus on Functional Bloating and Abdominal Distension—An ESNM/UEG Recommendations for Clinical Management	12
Overview of a national endoscopy database: The Trans.IT database and its impact on data registration quality	12
Comparative Study on Burden, Features and Determinants of Disorders of Gut‐Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Stu	12
	12
SARS‐Cov‐2 vaccination is safe in autoimmune pancreatitis patients	12
Best of UEG Week 2024	12
Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients	11
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus	11
A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum	11
Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males	11
Pre‐Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long‐Term Albumin in Patients With Cirrhosis and Ascites	11
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history	11
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection	11
Systemic therapies in hepatocellular carcinoma: A revolution?	11

Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted‐screening analysis case‐control study (PESTIPAC)	11
A rare case of squamous cell carcinoma originating from esophageal papilloma	11
Rare Case of Mantle Cell Lymphoma With Multiple Rectal Lesions	11
Was Motorized Spiral Enteroscopy Too Risky? A Systematic Review and Meta‐Analysis Including German Registry Data	11
Correction to “The Impact of Endoscopic Ultrasound and Multidisciplinary Team Evaluation on the Management of Pancreatic Cystic Lesions”	11
	10
Preclinical IBD: One more piece of the puzzle	10
Remimazolam Preserves Oxygen Reserve and Improves Sedation Safety Compared to Propofol in Endoscopic Retrograde Cholangiopancreatography	10
Abdominal Bloating and Distension: Common Symptoms but Limited Evidence	10
Tofacitinib in chronic pouchitis: A step towards addressing an unmet need	10
‘Call for More Biopsies During Pouchoscopy in Ulcerative Colitis’	10
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations	10
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—Sequelae to oncological diseases	10
UEG Week 2025 Poster Presentations	10
Intra‐abdominal abscesses in CD – When to treat with biologics?	10
Quality of clinical guidelines: It matters as it impacts patient care	10
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma	10
Thrombolysis for haemobilia‐induced biliary obstruction through a cholangiodrainage catheter	10
UEG Journal's impact and vision for the future	10
Asymptomatic Walled‐Off Pancreatic Necrosis: A Prospective Study of Natural Course and Risk Factors for Intervention	10
Issue Information	10
	10
The Learning Curve of Junior Endoscopists in EUS‐Guided Gastroenterostomy With the Wireless Simplified Technique: A Prospective Study	10
Adiposity as a risk factor for inflammatory bowel disease and the mediating effect of metabolic and inflammatory status: A population‐based cohort study	9
The Changing Landscape in Patients With Crohn's Disease	9
Clinical features and long‐term outcomes of patients with type 2 autoimmune pancreatitis	9
Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real‐World Cohort Study	9
Response to Letter to the Editor	9
New insights in the natural course of eosinophilic esophagitis	9
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight‐control strategy?	9
In memoriam: Rolf Hultcrantz (1949–2022)	9
Autoimmune pancreatitis—New evidence for clinical management strategies	9
Correction to “Small and Stable Pancreatic Cysts Are Reassuring During Surveillance: Results From the PACYFIC Trial”	9
Bugs and germs in GI‐disease	9
UEG Week 2024 Poster Presentations	9
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis	9
Towards a robust and compact deep learning system for primary detection of early Barrett’s neoplasia: Initial image‐based results of training on a multi‐center retrospectively collected data set	9
Symptom profiles compatible with disorders of gut‐brain interaction (DGBI) in organic gastrointestinal diseases: A global population‐based study	9
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis	9
5G‐based remote magnetically controlled capsule endoscopy for examination of the stomach and small bowel	9
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients	9
Endoscopy‐Related Musculoskeletal Injuries: A Systematic Review and Meta‐Analysis on Prevalence, Risk Factors and Prevention	8
Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?	8
Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First‐Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countri	8
Training Allied Healthcare Professionals Maybe the Answer to Upscaling Gut‐Directed Hypnotherapy	8
Ulcerative colitis increases risk of hypertension in a UK biobank cohort study	8
Colorectal polyps: Targets for fluorescence‐guided endoscopy to detect high‐grade dysplasia and T1 colorectal cancer	8
Clinical Validation of a Generative AI System for Diagnosing Ampullary Lesions: A Multicenter Study	8
Computer‐aided diagnosis in real‐time endoscopy for all stages of gastric carcinogenesis: Development and validation study	8
Tofacitinib for the treatment of chronic pouchitis: A pilot study	8
Intestinal strictures in Crohn's disease: An update from 2023	8
Evaluation of gastroenterology training curriculum in Greece	8
Issue Information	8
Burden of obesity in gastrointestinal and liver diseases	8
Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies	8
Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta‐analysis	8
SARS‐CoV‐2 and immunosuppressors at cellular level: Some good news	8
Hearing what isn't said	8
Young GI Angle: The young perspective of the UEG White Book 2 by the Friends of the UEG Young Talent Group	8
Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach	7
Environmental and Inflammatory Factors Drive Perinuclear‐Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin Study	7
A NECessary Workup: Exploring the Rare Histology of an Esophageal Tumor	7
Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol‐associated liver disease	7
Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease	7
Issue Information	7
Towards a Greener IBD‐Care: Let's INTERACT!	7
Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures	7
Gastric emptying rate and relevance for symptoms	7
Acute psychological stress increases paracellular permeability and modulates immune activity in rectal mucosa of healthy volunteers	7
Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes	7
Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta‐analysis with pre and post‐test probability assessment	7
Waiting for Perfection or Acting on Reality? Burnout in Gastroenterology Needs Action Now	7
Patient and First‐Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease—A Multinational Survey	7
Nurse‐Administered Gut‐Directed Hypnotherapy for Irritable Bowel Syndrome: A Two‐Year Follow‐Up Study	7
Natural course of ulcerative colitis in China: Differences from the West?	7
Later‐Stage Diagnosis and Poorer Survival in Pancreatic Cancer Patients With Vague Symptoms: A Population‐Based Study	7
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease	6
Vedolizumab for Crohn's disease: Real‐world efficacy through a meta‐analytical lens	6
Manometric identikit of a functioning and effective fundoplication for gastroesophageal reflux disease in the high‐resolution manometry ERA	6
Identifying predictors for comorbidities related mortality versus pancreatic cancer related mortality in patients with intraductal papillary mucinous neoplasm	6
Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study	6
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease	6
Atezolizumab and bevacizumab for non‐resectable or metastatic combined hepatocellular‐cholangiocarcinoma: A multicentric retrospective study	6
Pancreatic cancer surveillance: Risk stratification of individuals with a germline CDKN2A pathogenic variant	6
High Burden of Pancreatic Surgery for Intraductal Papillary Mucinous Neoplasia With Low‐Grade Dysplasia and Benign Cysts: A Systematic Review and Meta‐Analysis	6
Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study	6
Fecal and Serum Metabolome in Crohn’s Disease is Linked With Future Flare	6
	6
An artificial intelligence‐driven scoring system to measure histological disease activity in ulcerative colitis	6
Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit	6
Advancing patient‐centered care: Recent developments in UEG's patient relations	6
Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes	6
Surveillance and Surgery for IPMN: An Urgent Call to Challenge the Status Quo!	6
Surfing the web as a patient with IBD: New horizons	6
Tackling Post‐Endoscopy Gastric Cancer in a Low‐Risk Area: Prevalence, Features, and Prevention Opportunities Through Better Clinical Practice	6